期刊文献+

血小板活化因子与脑缺血的相关性研究 被引量:3

The relationship between platelet activating factor(PAF) and cerebrovascular ischemia
下载PDF
导出
摘要 目的 研究血小板活化因子 (PAF)与脑缺血的相关性。方法 用簿层层析法测定了脑缺血和脑出血患者血中PAF水平。结果 脑缺血患者血中PAF水平急性期为 (1.521±0.288)nmol/ml,恢复期为 (1.045±0.221)nmol/ml,高于非脑血管病组的急性期[(0.670±0.179)nmol/ml]和恢复期[(0.661±0.172)nmol/ml]及健康对照组[分别(0.714±0.212)nmol/ml和 (0.702±0.201)nmol/ml] ,差别均有非常显著性意义 (均P<0.01)。脑出血患者血中PAF水平急性期[(1.180±0.292)nmol/ml]和恢复期[(1.108±0.295)nmol/ml]也均高于非脑血管病组和健康对照组 (均P<0.05)。 结论 PAF在脑缺血的发病过程中可能起重要作用。
出处 《浙江医学》 CAS 2001年第9期519-521,共3页 Zhejiang Medical Journal
基金 浙江省科技厅科研基金资助项目
  • 相关文献

参考文献1

二级参考文献2

  • 1Sajal Chakraborti,Sandip K. Batabyal,John R. Michael,Tapati Sanyal. Role of membrane associated serine esterase in the activation of phospholipase A2 by calcium ionophore (A23187) in pulmonary arterial smooth muscle cells[J] 1994,Molecular and Cellular Biochemistry(2):121~127
  • 2Jen-sie Tou. Platelet-activating factor regulates phospholipid metabolism in human neutrophils[J] 1989,Lipids(9):812~817

共引文献3

同被引文献33

  • 1张雄,吴茂成,董临江,卢华毓,吴跃刚,邹晓辉,黄如训,曾进胜,聂亚雄.血小板活化因子与增龄及动脉粥样硬化性脑梗死相关研究[J].中国老年学杂志,2005,25(3):242-244. 被引量:3
  • 2白文婷,陈立杰.大鼠脑缺血再灌注PAF、PAF受体基因表达的变化[J].卒中与神经疾病,2005,12(2):84-86. 被引量:9
  • 3孙洪涛,顾成东,李刚,周同亮,张国强.血小板活化因子在心肌梗死患者中的水平变化[J].中国急救医学,2006,26(2):104-106. 被引量:5
  • 4YAMADA Y,YASHIDA H,ICHIHARA S.et al.Correlation between plasma platelel-activating factor acelylhydrolase(PAF-AH)activity and PAF-AH genotypo,age,and atherosclerosis in a Japanese population[J].Atherosclerosis,2000,150(1):209-216.
  • 5NINIO E.Phospholipid mediators in the vessel wall:involvement in atherosclerosis[J].Curr opin Clin Nutr Metab Care,2005,8(2):123-131.
  • 6CARTER A M.Inflammation.thrombosis and acute coronary syndromes[J].Diab Vasc Dis Res,2005,2(3):113-121.
  • 7SUBBANAGOuNDER G,LEITINGER N.SHIN P T.et al.Evidence that phospholipid oxidation and/or platelet activating factor play an important role in early atherogenesis.In vitro and in vivo inhibition by WEB2086[J].Circ Res,1999,85(4):311-318.
  • 8中华医学会神经病学分会.脑血管疾病分类和诊断要点.中华神经科杂志,1996,:379-381.
  • 9Yu CM, Zhang Q, Lam L, et al. Comparison of intensive and low - dose atorvastatin therapy in the reduction of carotid intimal - medial thickness in patients with coronary heart disease [ J ]. Heart, 2007, 93 (8) : 933 - 939.
  • 10Schuster H, Barter PJ, Stender S, et al. Effects of swiching statins on achievement of lipid goals : Measuring Effective Reduc- tions in Cholesterol Using Rosuvastatin Therapy ( MERCURY II ) study[J]. Am Heart J, 2004, 147(4) : 705 -713.

引证文献3

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部